GIUGGIOLI, DILIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 38.774
EU - Europa 18.446
AS - Asia 16.243
SA - Sud America 2.228
Continente sconosciuto - Info sul continente non disponibili 616
AF - Africa 407
OC - Oceania 47
Totale 76.761
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 37.781
IT - Italia 7.365
SG - Singapore 4.821
GB - Regno Unito 4.733
CN - Cina 4.244
HK - Hong Kong 1.822
BR - Brasile 1.705
VN - Vietnam 1.496
SE - Svezia 1.237
BD - Bangladesh 1.119
DE - Germania 988
FI - Finlandia 888
FR - Francia 783
UA - Ucraina 603
RU - Federazione Russa 580
KR - Corea 559
TR - Turchia 540
CA - Canada 524
IN - India 421
ID - Indonesia 304
NL - Olanda 266
BG - Bulgaria 233
MX - Messico 204
AR - Argentina 193
JP - Giappone 172
ZA - Sudafrica 134
IE - Irlanda 101
ES - Italia 100
IQ - Iraq 99
PL - Polonia 97
AE - Emirati Arabi Uniti 89
PK - Pakistan 82
CO - Colombia 71
AT - Austria 70
EC - Ecuador 70
MY - Malesia 68
BE - Belgio 57
EG - Egitto 54
LT - Lituania 52
CR - Costa Rica 51
CL - Cile 48
MA - Marocco 47
VE - Venezuela 47
SA - Arabia Saudita 46
TN - Tunisia 44
PH - Filippine 43
AU - Australia 42
JM - Giamaica 41
RO - Romania 41
IR - Iran 38
CZ - Repubblica Ceca 33
PE - Perù 32
CH - Svizzera 31
NP - Nepal 31
PY - Paraguay 29
TH - Thailandia 29
BZ - Belize 28
UZ - Uzbekistan 28
KE - Kenya 26
JO - Giordania 24
TW - Taiwan 23
AZ - Azerbaigian 19
EE - Estonia 19
TT - Trinidad e Tobago 19
AL - Albania 18
SV - El Salvador 18
ET - Etiopia 17
HN - Honduras 17
OM - Oman 17
PT - Portogallo 17
GR - Grecia 16
HU - Ungheria 16
DZ - Algeria 15
GT - Guatemala 15
BY - Bielorussia 14
IL - Israele 14
UY - Uruguay 14
BO - Bolivia 13
EU - Europa 13
DO - Repubblica Dominicana 12
LV - Lettonia 12
PR - Porto Rico 12
BB - Barbados 11
KZ - Kazakistan 11
NI - Nicaragua 11
SC - Seychelles 11
SN - Senegal 11
DK - Danimarca 10
PS - Palestinian Territory 10
KG - Kirghizistan 9
NO - Norvegia 9
RS - Serbia 9
BH - Bahrain 8
GE - Georgia 8
NG - Nigeria 8
SY - Repubblica araba siriana 8
LU - Lussemburgo 7
MD - Moldavia 7
QA - Qatar 7
SI - Slovenia 7
Totale 76.016
Salva come PNG Salva come JPEG
Città #
Ashburn 4.415
Southend 3.361
Santa Clara 3.261
Singapore 3.072
Fairfield 2.600
San Jose 2.217
Hong Kong 1.793
Council Bluffs 1.592
Woodbridge 1.484
Hefei 1.420
Chandler 1.325
Houston 1.233
Seattle 980
Chicago 969
Jacksonville 958
Wilmington 922
Los Angeles 907
Cambridge 830
Ann Arbor 741
London 691
Nyköping 679
Helsinki 668
Beijing 653
Dearborn 623
Milan 613
New York 573
Seoul 507
Ho Chi Minh City 479
Rome 470
Salt Lake City 429
The Dalles 425
Modena 404
Hanoi 376
Izmir 299
San Diego 293
Buffalo 258
Lauterbourg 253
Dallas 250
Bologna 248
Princeton 239
Sofia 224
Jakarta 220
São Paulo 219
Tampa 200
Columbus 185
Elk Grove Village 173
Naples 165
Moscow 162
Eugene 157
Atlanta 156
Shanghai 155
Frankfurt am Main 153
Toronto 152
Phoenix 144
Boardman 140
Florence 140
Orem 122
Bremen 121
Palermo 115
Des Moines 105
Tokyo 105
Redwood City 104
Mexico City 93
Munich 93
Denver 89
Guangzhou 87
Turin 86
Montreal 85
Bari 83
Lancaster 83
Catania 82
Dublin 81
Sterling 80
Detroit 79
Miami 79
Parma 77
Warsaw 73
Da Nang 70
Chennai 66
Kent 66
Genoa 65
Johannesburg 64
Brooklyn 62
Falls Church 59
Haiphong 59
Verona 59
Reggio Emilia 56
San Francisco 56
Amsterdam 55
Redondo Beach 54
Stockholm 52
Norwalk 51
Philadelphia 51
Manchester 50
Dulles 49
Charlotte 47
Padova 47
Boston 45
New Delhi 44
North Bergen 44
Totale 49.448
Salva come PNG Salva come JPEG
Nome #
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. 3.906
ALTERAZIONI CAPILLAROSCOPICHE IN CORSO DI DERMATOMIOSITE E SCLEROSI SISTEMICA; VERSO L’INDIVIDUAZIONE DI PATTERN SPECIFICI 992
HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC) 795
Thyroid Involvement in Hepatitis C Virus-Infected Patients with/without Mixed Cryoglobulinemia 771
Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. 508
Evoluzione dello CSURI (Capillaroscopic Skin Ulcer Risk Index) in pazienti affetti da sclerosi sistemica in terapia con antiendotelina-1 e prostanoidi 489
Oxycodone in the Long-Term Treatment of Chronic Pain Related to Scleroderma Skin Ulcers. 489
Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. 473
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 459
Systemic sclerosis progression INvestiGation (SPRING) Italian registry: Demographic and clinico-serological features of the scleroderma spectrum 453
Mixed cryoglobulinemia: Demographic, clinical, and serologic features and survival in 231 patients 407
Nailfold Videocapillaroscopy Alterations in Dermatomyositis and Systemic Sclerosis: Toward Identification of a Specific Pattern 405
Effect of treatment with iloprost with or without bosentan on nailfold videocapillaroscopic alterations in patients with systemic sclerosis 404
Heart involvement and systemic sclerosis 402
Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature. 398
Thymus alterations and systemic sclerosis 395
Radiological thymus alterations in systemic sclerosis: our experience and a review of the literature. 393
Hepatitis C virus infection and type 1 and type 2 diabetes mellitus 390
D-penicillamine in the treatment of eosinophilic fasciitis: case reports and review of the literature. 389
Breast cancer in systemic sclerosis: Results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature 389
CXCL10 (α) and CCL2 (β) chemokines in systemic sclerosis - A longitudinal study 384
Chemokines in the pathogenesis and as therapeutical markers and targets of HCV chronic infection, and HCV extrahepatic manifestations 383
Efficacia di terapia con immunoassorbimento con proteina A dello stafilococco e talidomide in un caso di dermatomiosite refrattaria. 382
Incidence of thyroid disorders in systemic sclerosis: results from a longitudinal follow-up. 382
Current treatment of hepatitis C-associated rheumatic diseases. 379
Human parvovirus B19 experimental infection in human fibroblasts and endothelial cells cultures 373
COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series 373
Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature 372
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection. 367
Scleroderma digital ulcers complicated by infection with fecal pathogens. 362
Targeting chemokine (C-X-C motif) receptor 3 in thyroid autoimmunity 361
Aortic pulse wave velocity measurement in systemic sclerosis patients. 360
Correlation of articular involvement, skin disfigurement, and unemployment with depressive symptoms in patients with systemic sclerosis: a hospital sample 358
Established coronary artery disease in systemic sclerosis compared to type 2 diabetic female patients: a cross-sectional study 358
Cardiac involvement in systemic sclerosis: identification of high-risk patient profiles in different patterns of clinical presentation 354
Cardio-pulmonary disease management in patients with systemic sclerosis: cardio-rheumatology clinic and patient care standardisation proposal 353
Elevated Troponin Serum Levels in Adult Onset Still's Disease 352
CAPILLAROSCOPIC SKIN ULCER RISK INDEX (CSURI) IN SYSTEMIC SCLEROSIS: RESULTS FROM AN ITALIAN MULTICENTER VALIDATION STUDY 342
Unusual association between Budd–Chiari syndrome secondary to antiphospholipid syndrome and relapsing polychondritis: a case report and review of the literature 342
Recombinant human erythropoietin stimulates vasculogenesis and wound healing in a patient with systemic sclerosis complicated by severe skin ulcers. 341
Treatment of severe scleroderma skin ulcers with recombinant human erythropoietin 340
Autoimmune and neoplastic thyroid diseases associated with hepatitis C chronic infection 340
L-Arginine in pregnant scleroderma patients 339
Thyroid involvement in patients with HCV-related mixed cryoglobulinaemia 338
Associations between Systemic Sclerosis and Thyroid Diseases 338
CORRELATION OF A QUANTITATIVE VIDEOCAPILLAROSCOPIC SCORE WITH THE DEVELOPMENT OF DIGITAL SKIN ULCERS IN SCLERODERMA PATIENTS 337
Capillaroscopic Skin Ulcers Risk Index (CSURI) calculated with different videocapillaroscopy devices: how its predictive values change 337
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature 337
Ultrasonography involvement of carotid, upper and lower limb arteries in a large cohort of systemic sclerosis patients 335
SAT0633-HPR Articular Involvement of the Scleroderma Hand: An Assessment Protocol for Planning Occupational Therapy Strategies 334
HCV associated cryoglobulinemic vasculitis 334
Antiendothelial cell antibodies induce apoptosis of bone marrow endothelial progenitors in systemic sclerosis 332
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 332
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 331
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 330
Parvoviral infection of endothelial cells and stromal fibroblasts: a possible pathogenetic role in scleroderma 327
Brief report: successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: an Italian multicenter study 326
Platelet gel in the treatment of severe scleroderma skin ulcers. 325
HHV-6A infection and systemic sclerosis: Clues of a possible association 324
Cryoglobulinemic vasculitis and skin ulcers. Our therapeutic strategy and review of the literature 319
Long-term treatment with rituximab in interstitial lung disease related to systemic sclerosis: our clinical experience 318
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 318
Insights into the knowledge of complex diseases: Environmental infectious/ toxic agents as potential etiopathogenetic factors of systemic sclerosis 313
CLINICAL AND PATHOLOGICAL FEATURES OF BREAST CANCER IN PATIENTS WITH SYSTEMIC SCLEROSIS: PRELIMINARY DATA FROM THE SCLERO-BREAST STUDY 310
HCV and cryoglobulinemic vasculitis. 308
Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications 307
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature 307
Successful treatment with leflunomide of arthritis in systemic sclerosis patients 303
Micro and Nanoparticles As Possible Causative-Prognostic Co-Factors Of Mixed Cryoglobulinemia Syndrome 301
Haematological Malignancies in Systemic Sclerosis Patients: Case Reports and Review of the World Literature 301
Cardiovascular risk and prostanoids in systemic sclerosis 299
Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients 299
[The alpha chemokine "Interferon gamma-induced protein 10" (IP-10) in Graves' disease and Graves'ophthalmopathy] 296
Micro and nanoparticles as possible pathogenetic co-factors in mixed cryoglobulinemia 295
Application of Agents Against Interferon-Gamma-Dependent Chemokines in Immunotherapy 293
Management of cardiopulmonary disease in patients with systemic sclerosis: cardiorheumatology clinic and patient care standardization proposal 293
Autologous skin grafting in the treatment of severe scleroderma cutaneous ulcers: a case report 291
Amlodipine in the treatment of Raynaud's phenomenon 291
Prediction risk chart for scleroderma digital ulcers: A composite predictive model based on capillaroscopic, demographic and clinico-serological parameters 290
Virus-driven autoimmunity and lymphoproliferation: the example of HCV infection 290
Induction of CXCL10 secretion by interferon-γ and tumour necrosis factor-α and its inhibition by peroxisome proliferator-activated receptor-γ agonists in cultured scleroderma fibroblasts. 290
UNCLASSIFIABLE INTERSTITIAL LUNG DISEASE OR UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE? A CHALLENGING DIFFERENTIAL DIAGNOSIS 290
The link between pain patient and analgesic medication is greater in migraine than in rheumatic disease patients 289
Polymyositis following Pandemic Influenza A (H1N1) and 2009-10 Seasonal Trivalent Vaccines 289
Correlation of a quantitative videocapillaroscopic score with the development of digital skin ulcers in scleroderma patients 288
Advanced oxidation protein products in serum of patients with systemic sclerosis: a possible indicator of clinical evolution 282
Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2 281
Use of Neem oil and Hypericum perforatum for treatment of calcinosis-related skin ulcers in systemic sclerosis 281
Autonomic dysfunction in systemic sclerosis: time and frequency domain 24 hour heart rate variability analysis 280
Scleroderma Digital Ulcers Complicated by Infection with Fecal Pathogens. 278
Photobiomodulation Therapy: A New Light in the Treatment of Systemic Sclerosis Skin Ulcers 277
Renal Manifestations of Hepatitis C Virus 276
The safety of iloprost in systemic sclerosis in a real-life experience 276
Systemic sclerosis following human cytomegalovirus infection 275
HCV-related rheumatic manifestations and therapeutic strategies 274
Assessing hand grasp in patients with systemic sclerosis using the 16-grasp test: Preliminary results from a multidisciplinary study group 273
Infezione da virus dell'epatite C e danno polmonare. 273
Autologous Fat Grafting for the Oral and Digital Complications of Systemic Sclerosis: Results of a Prospective Study 273
DIGITAL NECROSIS IN SYSTEMIC SCLEROSIS NOT ONLY A MICROVASCULAR DISEASE: A CASE REPORT 272
Measuring microangiopathy abnormalities in systemic sclerosis patients: the role of capillaroscopy-based scoring models 271
Totale 38.851
Salva come PNG Salva come JPEG
Categoria #
all - tutte 293.112
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 293.112
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.466 0 0 0 386 166 334 194 269 463 381 741 532
2022/20235.029 579 419 282 369 592 677 260 478 651 153 324 245
2023/20244.331 184 282 254 492 753 327 363 472 109 237 349 509
2024/202512.041 472 216 243 827 2.233 1.779 830 635 1.329 769 1.254 1.454
2025/202626.057 1.487 901 1.908 3.429 4.661 1.679 2.907 1.147 2.189 2.092 2.084 1.573
2026/20277.742 1.058 1.873 2.034 2.777 0 0 0 0 0 0 0 0
Totale 76.761